Acumen pharmaceuticals to participate in the bank of america healthcare conference

Newton, mass., may 07, 2025 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of alzheimer's disease, announced today that management will participate in in a fireside chat at the bank of american healthcare conference on wednesday, may 14, 2025, at 8:15 a.m. pt/11:15 a.m. et.
ABOS Ratings Summary
ABOS Quant Ranking